{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:40:19Z","timestamp":1762954819148},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T00:00:00Z","timestamp":1251244800000},"content-version":"vor","delay-in-days":4196,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[1998,3]]},"abstract":"<jats:p>To evaluate the socio\u2010economic effects of <jats:italic>Helicobacter pylori<\/jats:italic> eradication in the treatment of duodenal ulcer disease in Japan, a clinical decision analysis was performed to assess <jats:italic>H. pylori<\/jats:italic> eradication therapy compared with the conventional strategy of maintenance with histamine\u20102 receptor antagonists. A decision tree\u2010based state transition model (Markov chain approach) implemented to simulate a 5 year period of follow up was constructed. The <jats:italic>H. pylori<\/jats:italic> eradication strategy was found to be superior to the conventional maintenance strategy with regard to clinical effectiveness and other dimensions of a patient\u2019s outcome. Furthermore, in a long\u2010term perspective, the eradication strategy was less costly than the maintenance strategy. <jats:italic>Helicobacter pylori<\/jats:italic> eradication should be recommended as the \ufb01rst choice treatment of <jats:italic>H. pylori<\/jats:italic>\u2010positive duodenal ulcer patients. The clinical implication of <jats:italic>H. pylori<\/jats:italic> eradication entails an improvement in clinical effectiveness and other dimensions of a patient\u2019s outcome and a signi\ufb01cant reduction in the costs of duodenal ulcer treatment. The long\u2010term total costs do not depend on the initial drug cost of an eradication regimen. Pursuing a high eradication rate of <jats:italic>H. pylori<\/jats:italic> is essential in improving the patient\u2019s outcome and the cost\u2010effectiveness of treatment.<\/jats:p>","DOI":"10.1111\/j.1440-1746.1998.01556.x","type":"journal-article","created":{"date-parts":[[2009,4,22]],"date-time":"2009-04-22T11:37:43Z","timestamp":1240400263000},"page":"280-287","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Economic evaluation of <i>Helicobacter pylori<\/i> eradication for the treatment of duodenal ulcer disease in Japan: A decision analysis to assess eradication strategy in comparison with a conventional strategy"],"prefix":"10.1111","volume":"13","author":[{"given":"YASUKI","family":"HABU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIDETO","family":"INOKUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEISUKE","family":"KIYOTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KYOHEI","family":"HAYASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHIYUKI","family":"WATANABE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEIICHI","family":"KAWAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NILS\u2010OLOV","family":"ST\u00c5LHAMMAR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,26]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"LamSK HuiWM ChingCK. Peptic ulcer disease. Epidemiology pathogenesis and etiology. In: Haubrich WS Schaffner F Berk JE eds.Gastroenterology5th edn. Philadelphia: Saunders 1995; 700\u201348."},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02779315"},{"key":"e_1_2_6_4_2","first-page":"1121","article-title":"Changing trends in peptic ulcer disease in Japan. The epidemiological aspects","volume":"16","author":"Habu Y","year":"1993","journal-title":"Gastroenterol. Surg."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90599-1"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)90511-8"},{"key":"e_1_2_6_7_2","first-page":"76","article-title":"The role of infectious agents in peptic ulcer disease","volume":"6","author":"Tytgat GNJ","year":"1993","journal-title":"Gastroenterology Int."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409091407"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archinte.1995.00430090057007","article-title":"Costs of duodenal ulcer therapy with antibiotics","volume":"155","author":"Sonnenberg A","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.155.18.1958"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199508050-00005"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-4-199508150-00003"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X8300300403"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309098347"},{"key":"e_1_2_6_15_2","first-page":"995","article-title":"Omeprazole 20 or 40mg daily for healing of duodenal ulcer? A double\u2010blind comparative study","volume":"4","author":"Lauritsen K","year":"1992","journal-title":"Eur J. Gastroenterol. Hepatol."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199142010-00008"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0016-5085(77)80196-0","article-title":"Gastric and duodenal ulcer healing and placebo treatment","volume":"72","author":"Scheurer U","year":"1977","journal-title":"Gastroenterology"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199305000-00005"},{"key":"e_1_2_6_19_2","first-page":"S116","article-title":"Helicobacter pylori","volume":"89","author":"Marshall BJ","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_20_2","first-page":"491","article-title":"Omeprazole plus amoxicillin: ef\ufb01cacy of various treatment regimens to eradicate Helicobacter pylori","volume":"88","author":"Labenz J","year":"1993","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_21_2","first-page":"726","article-title":"Medium\u2010 or high\u2010dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease","volume":"89","author":"Labenz J","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02088052"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409091408"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91111-8"},{"key":"e_1_2_6_25_2","first-page":"1242","article-title":"H2\u2010receptor antagonists and duodenal ulcer recurrence: Analysis of ef\ufb01cacy and commentary on safety, costs, and patient selection","volume":"82","author":"Freston JF","year":"1987","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_26_2","article-title":"Omeprazole or ranitidine in duodenal ulcer prevention? Double\u2010blind comparative trial","volume":"104","author":"Lauritsen K","year":"1993","journal-title":"Gastroenterology"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528708991481"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1992.tb00577.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1005771"},{"key":"e_1_2_6_30_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1994.03520010077036","article-title":"Helicobacter pylori in peptic ulcer disease","volume":"272","author":"National Institute of Health Consensus Conference","year":"1994","journal-title":"JAMA"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.1998.01556.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.1998.01556.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1440-1746.1998.01556.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.1998.01556.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T09:58:28Z","timestamp":1694426308000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.1998.01556.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["10.1111\/j.1440-1746.1998.01556.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.1998.01556.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]},"assertion":[{"value":"2009-08-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}